# Food and Drug Administration (FDA)

Type: organization

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/food-and-drug-administration-fda
Canonical HTML page: https://getlegalbrief.com/entity/food-and-drug-administration-fda

## Timeline

- **2026-07**: ALJ Hearing on Marijuana Rescheduling — A seven-day administrative hearing is held in Arlington, Virginia, debating whether marijuana has a 'currently accepted medical use' without MMJ's testimony or evidence.
- **2026-06**: DEA Excludes MMJ from Rescheduling Hearing — The DEA denies MMJ International Holdings' request to participate in the upcoming administrative hearing, asserting that its evidence raises only questions of law.
- **2026-05-03**: Federal Appeals Court Bans Mailing Mifepristone — A federal appeals court made it illegal to mail mifepristone, a key medication abortion pill, threatening telehealth access.
- **2026-05**: Supreme Court Issues Stay on Mifepristone Ban — The Supreme Court stayed the appeals court ruling, allowing mailing to continue while the legal challenge proceeds.
- **2026-Q2 (projected)**: Legal Challenges — Expected filing of lawsuits by environmental groups to block the relaxation of standards.
- **2026-03-13**: EPA Rollback Proposal — The EPA announces moves to weaken the previously established pollution limits.
- **2025-Q3**: Industry Petitions — Medical tech groups and the FDA raise alarms about potential device shortages due to facility closures.
- **2024-03**: Strict Standards Finalized — EPA issues a rule requiring a 90% reduction in EtO emissions from sterilization plants.
- **2022-06-24**: Supreme Court Overturns Roe v. Wade in Dobbs Decision — The landmark ruling eliminated the constitutional right to abortion, allowing states to enact bans.

## Recent coverage (4 stories)

### DEA Excluded MMJ, Only FDA-Pathway Developer with $10M in Research, from Rescheduling Hearing
2026-07-13 06:01:24 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

MMJ International Holdings alleges the DEA violated administrative law by excluding it from marijuana rescheduling hearings, despite spending $10 million on FDA-pathway development. The exclusion raises due process and APA concerns that could imperil the final rule.
Full story: https://getlegalbrief.com/story/dea-excludes-mmj-fda-cannabinoid-rescheduling-hearing

### Abortions Surge 100% Post-Roe: How Telehealth Pills Exploit Legal Gaps
2026-06-28 09:16:18 · Sentiment: Neutral · Impact: 7/10 · Sources: 23

Despite state bans, U.S. abortions nearly doubled, fueled by telehealth pill delivery across state lines. This exposes legal tensions between state authority, FDA preemption, and 19th-century obscenity statutes.
Full story: https://getlegalbrief.com/story/abortions-surge-telehealth-legal

### EPA Signals Regulatory Pivot by Weakening Medical Sterilization Emission Limits
2026-03-13 21:21:24 · Sentiment: Bearish · Impact: 7/10 · Sources: 3

The Environmental Protection Agency has proposed a relaxation of pollution standards for chemicals used in medical equipment sterilization, specifically targeting Ethylene Oxide (EtO). This move attempts to balance carcinogenic health risks against the critical need to maintain the national medical device supply chain.
Full story: https://getlegalbrief.com/story/epa-weakens-medical-sterilization-pollution-limits

### FDA to Incentivize Faster Drug Approvals via New Staff Bonus Program
2026-02-26 23:36:59 · Sentiment: Bullish · Impact: 7/10 · Sources: 5

The U.S. Food and Drug Administration is implementing a performance-based bonus structure to reward staffers who complete drug reviews ahead of schedule. This initiative aims to accelerate the therapeutic pipeline but has sparked immediate debate over the potential impact on safety standards and regulatory rigor.
Full story: https://getlegalbrief.com/story/fda-bonus-payments-speedy-drug-reviews

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.